Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 0 · FY2024 889 — 3-yr total 889
Operates in Medical Devices — Distribution. Per the activity note to the FY2024 annual report, the company trades in medical equipment and medical supplies through re-export. Parent company is Estonian private company MN Medical.
Subsidiary of Shezghuduli Pasukhismgeblobis Kerdzo Company MN MEDICAL (100.0%)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 78 | 23 | 772 | 158 | 103 | 207 | 202 | +17.1% |
| Net Cash used in Investing Activities | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
| Free Cash Flow (OCF − Capex proxy) | 78 | 23 | 772 | 157 | 103 | 207 | 202 | +17.1% |
| Net Cash from Financing Activities | 0 | 0 | 0 | 154 | 0 | 0 | 0 | |
| Net Change in Cash (before FX) | 78 | 23 | 772 | 3 | 103 | 207 | 202 | +17.1% |
| Effect of FX on Cash | 0 | 21 | 16 | 87 | 74 | 127 | 11 | nmf |
| Net Change in Cash (incl. FX) | 78 | 44 | 788 | 90 | 177 | 80 | 192 | +16.0% |
| Cash at Beginning of Year | 0 | 124 | 169 | 957 | 1,046 | 870 | 950 | +50.1% |
| Cash at End of Year | 0 | 169 | 957 | 1,046 | 870 | 950 | 1,141 | +46.6% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.